TI
ALT icon

Trexquant Investment’s Altimmune ALT Stock Holding History

Trexquant Investment’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,113
Closed -$234K – 1504
2024
Q2 		$234K Buy
+35,113
New +$259K ﹤0.01% 1419
2022
Q2 		– Sell
-99,269
Closed -$605K – 1489
2022
Q1 		$605K Buy
99,269
+15,134
+18% +$111K 0.03% 677
2021
Q4 		$771K Buy
84,135
+66,091
+366% +$702K 0.05% 475
2021
Q3 		$204K Buy
+18,044
New +$219K 0.02% 952
2021
Q2 		– Sell
-30,951
Closed -$437K – 1058
2021
Q1 		$437K Buy
+30,951
New +$500K 0.04% 570

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Trexquant Investment's ALT Position: Q3 2024 in Review

Trexquant Investment sold out of Altimmune (ALT) in Q3 2024, closing a stake of 35,113 shares — an estimated $234K sold.

Trexquant Investment first reported a position in ALT in Q1 2021 and held it in 5 quarters. The position peaked at $771K in Q4 2021. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

  • Trexquant Investment reported no remaining Altimmune position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 35,113 Altimmune shares in Q3 2024, an estimated $234K.
  • Trexquant Investment first reported a position in Altimmune in Q1 2021 and held it in 5 quarters.
  • Trexquant Investment's Altimmune position peaked at $771K in Q4 2021.
  • 169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.